Skip to main content
SpringerLink
Log in

Epidemiology, Pathogenesis, and Prognosis of Uncommon Liver Tumors

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 660 Accesses

Abstract

Although far less common than hepatic metastases, hepatocellular carcinoma (HCC), and cholangiocarcinoma (CCA), other relatively rare hepatic lesions are infrequently encountered. These lesions are often not discussed and less likely to be considered in the differential diagnosis of hepatic masses found either in symptomatic patients or incidentally. Given the rarity of some lesions, arriving at a definitive diagnosis and management plan can be particularly challenging. In this chapter, we present an overview of epidemiology, pathogenesis, and prognosis of uncommon hepatic tumors derived from available literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kumar A, Sharma B, Samant H. Cancer, liver angiosarcoma. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2020 [cited 2020 Mar 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK538224/

  2. Fayette J, Martin E, Piperno-Neumann S, Cesne AL, Robert C, Bonvalot S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18(12):2030–6.

    CAS  Google Scholar 

  3. Forbes A, Portmann B, Johnson P, Williams R. Hepatic sarcomas in adults: a review of 25 cases. Gut. 1987;28(6):668–74.

    CAS  Google Scholar 

  4. Chaudhary P, Bhadana U, Singh RAK, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015;41(9):1137–43.

    CAS  Google Scholar 

  5. Zhu Y-P, Chen Y-M, Matro E, Chen R-B, Jiang Z-N, Mou Y-P, et al. Primary hepatic angiosarcoma: a report of two cases and literature review. World J Gastroenterol. 2015;21(19):6088–96.

    Google Scholar 

  6. Primary hepatic angiosarcoma: a case-based discussion of unique presentations and extrahepatic manifestations. Elsevier Enhanced Reader [Internet]. [cited 2020 Aug 11]. Available from: https://reader.elsevier.com/reader/sd/pii/S2666621920300120?token=05A58E9B92C8196D968643601E00206DE89D2EA091A0F27C02D57492DE5A04B5F2D9417E20A857F35A664DBEB3D84CFE

  7. Zheng Y, Zhang X, Zhang J, Hui Z, Du W, Li R, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol. 2014;29(5):906–11.

    CAS  Google Scholar 

  8. Huang N-C, Kuo Y-C, Chiang J-C, Hung S-Y, Wang H-M, Hung Y-M, et al. Hepatic angiosarcoma may have fair survival nowadays. Medicine [Internet]. 2015 May 21 [cited 2020 Mar 6];94(19):e816. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602568/

  9. Li Z, Sun H, Shen C, Yang C, Wang Y, Wang W, et al. Primary hepatic angiosarcoma with spleen metastases in an adult woman: a case report and literature review. Int J Clin Exp Pathol. 2017;10(11):11211–8.

    Google Scholar 

  10. Sherman M. Vinyl chloride and the liver. J Hepatol. 2009;51(6):1074–81.

    CAS  Google Scholar 

  11. Elliott P, Kleinschmidt I. Angiosarcoma of the liver in Great Britain in proximity to vinyl chloride sites. Occup Environ Med. 1997;54(1):14–8.

    CAS  Google Scholar 

  12. Weber E, Laarbaui F, Michel L, Donckier J. Abdominal pain: do not forget Thorotrast! Postgrad Med J. 1995;71(836):367–8.

    CAS  Google Scholar 

  13. Lipshutz GS, Brennan TV, Warren RS. Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg. 2002;195(5):713–8.

    Google Scholar 

  14. Kim HR, Rha SY, Cheon SH, Roh JK, Park YN, Yoo NC. Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma. Ann Oncol. 2009;20(4):780–7.

    CAS  Google Scholar 

  15. Geller RL, Hookim K, Sullivan HC, Stuart LN, Edgar MA, Reid MD. Cytologic features of angiosarcoma: a review of 26 cases diagnosed on FNA. Cancer Cytopathol. 2016;124(9):659–68.

    CAS  Google Scholar 

  16. Montell García M, Romero Cabello R, Romero Feregrino R, Atri Moises M, Trejo Estrada R, Alvaro P-R, et al. Angiosarcoma of the liver as a cause of fulminant liver failure. BMJ Case Rep [Internet]. 2012 Aug 2 [cited 2020 Aug 11];2012:bcr2012006417. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543703/

  17. Lazăr DC, Avram MF, Romoșan I, Văcariu V, Goldiș A, Cornianu M. Malignant hepatic vascular tumors in adults: characteristics, diagnostic difficulties and current management. World J Clin Oncol. 2019;10(3):110–35.

    Google Scholar 

  18. Fields BKK, Matcuk GR, Lai D, Lee A, Dwabe S, Hanlon C, et al. Primary hepatic angiosarcoma: a case-based discussion of unique presentations and extrahepatic manifestations. Curr Probl Cancer Case Rep. 2020;1:100012.

    Google Scholar 

  19. Tripke V, Heinrich S, Huber T, Mittler J, Hoppe-Lotichius M, Straub BK, et al. Surgical therapy of primary hepatic angiosarcoma. BMC Surg [Internet]. 2019 Jan 10 [cited 2020 Mar 6];19:5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329081/

  20. Rosen EA, Vallurupalli M, Choy E, Lennerz JK, Kuter DJ. Management of disseminated intravascular coagulation in a patient with hepatic angiosarcoma. Medicine [Internet]. 2018 Nov 21 [cited 2020 Mar 6];97(47):e13321. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392710/

  21. Choi KH, Moon WS. Epithelioid hemangioendothelioma of the liver. Clin Mol Hepatol. 2013;19(3):315.

    Google Scholar 

  22. Liu YI, Brown SS, Elihu A, Bonham CA, Concepcion W, Longacre TA, et al. Hepatic epithelioid hemangioendothelioma. Dig Dis Sci. 2011;56(2):303–6.

    Google Scholar 

  23. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver. Cancer. 1999;85(3):562–82.

    CAS  Google Scholar 

  24. Treska V, Daum O, Svajdler M, Liska V, Ferda J, Baxa J. Hepatic epithelioid hemangioendothelioma – a rare tumor and diagnostic dilemma. In Vivo. 2017;31(4):763–7.

    CAS  Google Scholar 

  25. Taniai T, Onda S, Sato S, Shiba H, Sakamoto T, Yanaga K. Hepatic epithelioid hemangioendothelioma: difficult differential diagnosis from angiosarcoma. Case Rep Gastroenterol. 2020;14(1):56–62.

    Google Scholar 

  26. Yang J-W, Li Y, Xie K, Dong W, Cao X-T, Xiao W-D. Spontaneous rupture of hepatic epithelioid hemangioendothelioma: a case report. World J Gastroenterol. 2017;23(1):185–90.

    Google Scholar 

  27. Dong K, Wang X-X, Feng J-L, Liu H, Zu K-J, Chang J, et al. Pathological characteristics of liver biopsies in eight patients with hepatic epithelioid hemangioendothelioma. Int J Clin Exp Pathol. 2015;8(9):11015–23.

    Google Scholar 

  28. Remiszewski P, Szczerba E, Kalinowski P, Gierej B, Dudek K, Grodzicki M, et al. Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation. World J Gastroenterol. 2014;20(32):11333–9.

    Google Scholar 

  29. Lenze F, Birkfellner T, Lenz P, Hussein K, Länger F, Kreipe H, et al. Undifferentiated embryonal sarcoma of the liver in adults. Cancer. 2008;112(10):2274–82.

    Google Scholar 

  30. Ma L, Liu Y-P, Geng C-Z, Tian Z-H, Wu G-X, Wang X-L. Undifferentiated embryonal sarcoma of liver in an old female: case report and review of the literature. World J Gastroenterol. 2008;14(47):7267–70.

    Google Scholar 

  31. Mori A, Fukase K, Masuda K, Sakata N, Mizuma M, Ohtsuka H, et al. A case of adult undifferentiated embryonal sarcoma of the liver successfully treated with right trisectionectomy: a case report. Surg Case Rep [Internet]. 2017 Jan 31 [cited 2020 Aug 22];3:19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285294/

  32. Noguchi K, Yokoo H, Nakanishi K, Kakisaka T, Tsuruga Y, Kamachi H, et al. A long-term survival case of adult undifferentiated embryonal sarcoma of liver. World J Surg Oncol. 2012;10:65.

    Google Scholar 

  33. Kallam A, Krishnamurthy J, Kozel J, Shonka N. Undifferentiated embryonal sarcoma of liver. Rare Tumors [Internet]. 2015 Dec 30 [cited 2020 Aug 16];7(4):215. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703922/

  34. Li X-W, Gong S-J, Song W-H, Zhu J-J, Pan C-H, Wu M-C, et al. Undifferentiated liver embryonal sarcoma in adults: a report of four cases and literature review. World J Gastroenterol. 2010;16(37):4725–32.

    Google Scholar 

  35. Cao Q, Ye Z, Chen S, Liu N, Li S, Liu F. Undifferentiated embryonal sarcoma of liver: a multi-institutional experience with 9 cases. Int J Clin Exp Pathol. 2014;7(12):8647–56.

    Google Scholar 

  36. Zhang H, Yu X, Xu J, Li J, Zhou Y. Combined hepatocellular-cholangiocarcinoma: an analysis of clinicopathological characteristics after surgery. Medicine. 2019;98(38):e17102.

    CAS  Google Scholar 

  37. Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, et al. Combined hepatocellular–cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl. 2014;20(8):952–9.

    Google Scholar 

  38. Ramai D, Ofosu A, Lai JK, Reddy M, Adler DG. Combined hepatocellular cholangiocarcinoma: a population-based retrospective study. Am J Gastroenterol. 2019;114(9):1496–501.

    Google Scholar 

  39. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma. Cancer. 2002;94(7):2040–6.

    Google Scholar 

  40. Stavraka C, Rush H, Ross P. Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. J Hepatocell Carcinoma. 2018;6:11–21.

    Google Scholar 

  41. Martin ED, Rayar M, Golse N, Dupeux M, Gelli M, Gnemmi V, et al. Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined hepatocellular–cholangiocarcinoma in the setting of cirrhosis. Liver Transpl. 2020;26(6):785–98.

    Google Scholar 

  42. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JHH, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular–cholangiocarcinoma. Am J Transplant. 2010;10(5):1263–7.

    CAS  Google Scholar 

  43. Kuo L-M, Chou H-S, Chan K-M, Yu M-C, Lee W-C. A case of huge primary liposarcoma in the liver. World J Gastroenterol. 2006;12(7):1157–9.

    Google Scholar 

  44. Binesh F, Akhavan A, Kargar S, Navabii H. Primary liposarcoma of liver: a rare case and literature review. BMJ Case Rep [Internet]. 2012 Jul 29 [cited 2020 Aug 29];2012:bcr0120125711. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543104/

  45. Liu W, Liang W, Peng Z. Positron emission tomography/computed tomography manifestations of primary hepatic myxoid liposarcoma. Medicine [Internet]. 2018 Sep 28 [cited 2020 Aug 29];97(39):e12307. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181573/

  46. Naik PRT, Kumar P, Kumar PV. Primary pleomorphic liposarcoma of liver: a case report and review of the literature. Case Rep Hepatol [Internet]. 2013 [cited 2020 Aug 29];2013:398910. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208437/

  47. Tos APD. Liposarcomas: diagnostic pitfalls and new insights. Histopathology. 2014;64(1):38–52.

    Google Scholar 

  48. Agmon-Levin N, Berger I, Shtalrid M, Schlanger H, Sthoeger ZM. Primary hepatic lymphoma: a case report and review of the literature. Age Ageing. 2004;33(6):637–40.

    Google Scholar 

  49. Cesaretti M, Loustau M, Robba C, Senescende L, Zarzavadjian Le Bian A. Reappraisal of primary hepatic lymphoma: is surgical resection underestimated? Crit Rev Oncol Hematol. 2018;123:1–6.

    Google Scholar 

  50. Myoteri D, Dellaportas D, Arkoumani E, Marinis A, Zizi-Sermpetzoglou A. Primary hepatic lymphoma: a challenging diagnosis. Case Rep Oncol Med. 2014;2014:1–3.

    Google Scholar 

  51. Forghani F, Masoodi M, Kadivar M. Primary hepatic lymphoma mimicking cholangiocarcinoma. Oman Med J. 2017;32(4):335–8.

    Google Scholar 

  52. Mehta N, Jayapal L, Goneppanavar M, Nelamangala Ramakrishnaiah VP. Primary hepatic lymphoma: a rare case report. JGH Open. 2019;3(3):261–3.

    Google Scholar 

  53. Mastoraki A, Stefanou MI, Chatzoglou E, Danias N, Kyriazi M, Arkadopoulos N, et al. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30(3):150–4.

    Google Scholar 

  54. Liao S-H, Chen Y-K, Yu S-C, Wu M-S, Wang H-P, Tseng P-H. An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review. SAGE Open Med Case Rep. 2017;5:2050313X17709190.

    Google Scholar 

  55. Okazaki M, Tajima H, Ohbatake Y, Shinbashi H, Nakanuma S, Makino I, et al. Pleomorphic rhabdomyosarcoma of the liver in an adult: a rare case report. BMC Surg [Internet]. 2020 Apr 21 [cited 2021 Jan 17];20:81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171846/

  56. Yin J, Liu Z, Yang K. Pleomorphic rhabdomyosarcoma of the liver with a hepatic cyst in an adult. Medicine [Internet]. 2018 Jul 20 [cited 2021 Jan 17];97(29):e11335. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086459/

  57. Schoofs G, Braeye L, Vanheste R, Verswijvel G, Debiec-Rychter M, Sciot R. Hepatic rhabdomyosarcoma in an adult: a rare primary malignant liver tumor. Case report and literature review. Acta Gastroenterol Belg. 2011;74(4):576–81.

    CAS  Google Scholar 

  58. Arora A, Jaiswal R, Anand N, Husain N. Primary embryonal rhabdomyosarcoma of the liver. BMJ Case Rep [Internet]. 2016 Dec 30 [cited 2021 Jan 17];2016:bcr2016218292. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237799/

  59. Chagas AL, Kikuchi L, Herman P, Alencar RSSM, Tani CM, Diniz MA, et al. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases. Clinics. 2015;70(3):207–13.

    Google Scholar 

  60. Riggle KM, Turnham R, Scott JD, Yeung RS, Riehle KJ. Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma. Pediatr Blood Cancer. 2016;63(7):1163–7.

    Google Scholar 

  61. Weeda VB, Murawski M, McCabe AJ, Maibach R, Brugières L, Roebuck D, et al. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer. 2013;49(12):2698–704.

    CAS  Google Scholar 

  62. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10. Gut. 2013;62(11):1667–8.

    Google Scholar 

  63. Kassahun WT. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol [Internet]. 2016 May 23 [cited 2020 Aug 29];14:151. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877801/

  64. Chaudhari VA, Khobragade K, Bhandare M, Shrikhande SV. Management of fibrolamellar hepatocellular carcinoma. Chin Clin Oncol. 2018;7(5):51. https://doi.org/10.21037/cco.2018.08.08.

    Article  Google Scholar 

  65. Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D’Angelica M, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer. 2006;106(6):1331–8.

    Google Scholar 

  66. Duan X-F, Zhao Q. Adult hepatoblastoma: a review of 47 cases. ANZ J Surg. 2018;88(1–2):E50–4.

    Google Scholar 

  67. Rougemont A-L. Adult hepatoblastoma: learning from children. J Hepatol. 2012;56:12.

    Google Scholar 

  68. Cienfuegos JA, Labiano T, Pedano N, Zozaya GN, Martí-Cruchaga P, Panizo Á, et al. Adult hepatoblastoma. Rev Esp Enferm Dig. 2013;105(4):229–31.

    Google Scholar 

  69. Zheng MH, Zhang L, Gu DN, Shi HQ, Zeng QQ, Chen YP. Hepatoblastoma in adult: review of the literature. J Clin Med Res. 2009;1(1):13–6.

    Google Scholar 

  70. Wang YX, Liu H. Adult hepatoblastoma: systemic review of the English literature. Dig Surg. 2012;29(4):323–30.

    CAS  Google Scholar 

  71. Blokhin I, Chernina V, Menglibaev M, Kalinin D, Schima W, Karmazanovsky G. Giant hepatic angiomyolipoma: a case report. BJR Case Rep [Internet]. 2018 Sep 14 [cited 2021 Jan 18];5(1):20180072. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519506/

  72. Liu J, Zhang C-W, Hong D-F, Tao R, Chen Y, Shang M-J, et al. Primary hepatic epithelioid angiomyolipoma: a malignant potential tumor which should be recognized. World J Gastroenterol. 2016;22(20):4908–17.

    CAS  Google Scholar 

  73. Ren N, Qin L-X, Tang Z-Y, Wu Z-Q, Fan J. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9(8):1856–8.

    Google Scholar 

  74. Yang C-Y, Ho M-C, Jeng Y-M, Hu R-H, Wu Y-M, Lee P-H. Management of hepatic angiomyolipoma. J Gastrointest Surg. 2007;11(4):452–7.

    Google Scholar 

  75. Klompenhouwer AJ, Verver D, Janki S, Bramer WM, Doukas M, Dwarkasing RS, et al. Management of hepatic angiomyolipoma: a systematic review. Liver Int. 2017;37(9):1272–80.

    Google Scholar 

  76. Günster SA, Kim M, Lock JF, Krajinovic K. Hepatic angiomyolipoma: a case report and literature review. Int J Surg Case Rep. 2020;77:345–8.

    Google Scholar 

  77. Kubo H, Yamazaki H, Okada T, Takahashi Y, Nishi Y, Yokomori H. Primary hepatic angiomyolipoma: immunohistochemistry and electron microscopic observations: a case report. J Med Case Rep [Internet]. 2017 Mar 22 [cited 2021 Jan 18];11:76. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361786/

  78. Petrolla AA, Xin W. Hepatic angiomyolipoma. Arch Pathol Lab Med. 2008;132(10):1679–82. https://doi.org/10.1043/1543-2165(2008)132[1679:HA]2.0.CO;2.

    Article  Google Scholar 

  79. Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, et al. Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol. 2010;11(5):560–5.

    Google Scholar 

  80. Ahadi M, Khosravi Khorashad A, Saadatnia H, Vosoughinia H, Davachi B, Farzanehfar M, et al. Resolution of bile duct adenoma over follow-up period; a case report. Middle East J Dig Dis. 2016;8(4):327–30.

    Google Scholar 

  81. Chen L, Xu MY, Chen F. Bile duct adenoma: a case report and literature review. World J Surg Oncol. 2014;12:125.

    Google Scholar 

  82. Johannesen EJ, Wu Z, Holly J-S. Bile duct adenoma with oncocytic features. Case Rep Pathol [Internet]. 2014 [cited 2021 Jan 18];2014:282010. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926226/

  83. Morris M, Anderson C, Drake L, Redfield S, Subramony C, Vanderlan W. Giant biliary cystadenoma. J Surg Case Rep. 2012;2012(9):15.

    Google Scholar 

  84. Soares KC, Arnaoutakis DJ, Kamel I, Anders R, Adams RB, Bauer TW, et al. Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. J Am Coll Surg. 2014;218(1):119–28.

    Google Scholar 

  85. Peh KH, Eugene Chan BT. Biliary cystadenoma: a rare occurrence. Med J Malaysia. 2020;75(3):307–8.

    CAS  Google Scholar 

  86. Xu R-M, Li X-R, Liu L-H, Zheng W-Q, Zhou H, Wang X-C. Intrahepatic biliary cystadenoma: a case report. World J Clin Cases. 2020;8(22):5670–7.

    Google Scholar 

  87. Bartolome MAH, Ruiz SF, Romero IM, Lojo BR, Prieto IR, Alvira LG, et al. Biliary cystadenoma. World J Gastroenterol. 2009;15(28):3573–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CT Gastroenterology Associates, Hartford, CT, USA

    Elizabeth Richardson

  2. Main Line Gastroenterology Associates, Collegeville, PA, USA

    Scott Fink

  3. Connecticut GI, Hartford, CT, USA

    Elizabeth Richardson

Authors
  1. Elizabeth Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Richardson, E., Fink, S. (2022). Epidemiology, Pathogenesis, and Prognosis of Uncommon Liver Tumors. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation